As of November 2026 SAB Biotherapeutics has a market cap of NZ$0.50 Billion. This makes SAB Biotherapeutics the world's 8552th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 10th, 2026 the market cap of SAB Biotherapeutics was reported to be: